Launch of a checklist for reporting longitudinal observational drug studies in rheumatology: a EULAR extension of STROBE guidelines based on experience from biologics registries.
Institute of Rheumatology, , Prague, Czech Republic.
Jakub
J
Zavada
William G
WG
Dixon
Johan
J
Askling
D016907:Adverse Drug Reaction Reporting Systems / Q000458:organization & administration*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001688:Biological Products / Q000009:adverse effects*; D006801:Humans; D012042:Registries / Q000592:standards*; D012216:Rheumatic Diseases / Q000188:drug therapy*
D018501:Antirheumatic Agents; D001688:Biological Products
DMARDs (biologic); DMARDs (synthetic); Epidemiology